EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 29 September 2022

News

‘TEE’ system will revitalise antibiotic research and save money for Europe, new evidence shows...
28 September 2022

New and novel antibiotics are urgently needed to help tackle the global health threat of antimicrobial resistance (AMR),... Read more

Blogs

We won’t rest until we improve outcomes for patients with even the most resistant leukaemias...
27 September 2022

As haematological cancer outcomes and survival rates continue to improve worldwide thanks to earlier diagnosis and advances... Read more

A spotlight on solid tumours: exploring the impact of a prostate, bladder or lung cancer diagnosis...
23 September 2022 - Catherine Taylor

Dr Cathy Taylor, Vice President EMEA Medical Affairs, Therapy Area Strategy at Janssen discusses how a diagnosis with... Read more

Events

New procedures and policies for the electronic Certificate of Pharmaceutical Product (eCPP)...
03 October 2022 (Virtual event)

With the participation of WHO and global regulators. Read more

Investor Perspective: The Strategic Venturing Spectrum
10 November 2022 (Hybrid)

Webinar by Johnson & Johnson Innovation Read more

EU HEALTH SUMMIT 2022: TOWARDS AN EU HEALTH UNION
15 November 2022 (Brussels)

An EU Health Coalition event Read more

Enhancing patient-centric outcome measures and clinical trials with Digital Health Technologies...
12 December 2022 (Virtual event)

Last chance to register! Read more

We are #MorethanMedicine

Medicines have added 1.2m years to the lives of breast cancer patients. But life-saving medicines are just the start of our work.
Find out more

What we are reading

SAATELLITE-2 Includes 1st Patient
On 29 September 2022 (COMBACTE)

Progressing the development of novel antibodies against AMR. Read more

Using real world data (RWD) from patient databases to understand who could benefit from treatment...
On 07 September 2022 (Data Saves Lives)

This case study shows how analysis of real-world patient data gathered from local Health Units can be a useful tool... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu